Supreme Court Urged to Settle Abortion Pill Debate in Landmark Case

The manufacturer of the abortion drug mifepristone has asked the Supreme Court to reverse a lower court ruling that would restrict access to the drug. The Supreme Court's decision, expected in 2024, could have significant implications for abortion access in the United States. The case centers around the scope of the FDA's authority to regulate mifepristone, a drug deemed safe and effective by the medical community. If the appeals court decision stands, access to mifepristone would be limited, making it harder for women to obtain abortions even in states where it is still legal. The Biden administration also plans to appeal the ruling.